These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22248154)

  • 1. Audit of insulin detemir in pregnancy: a retrospective case series.
    Shenoy VV; Cook SJ; Parry AF; McIntyre HD
    Diabet Med; 2012 Jul; 29(7):958-9. PubMed ID: 22248154
    [No Abstract]   [Full Text] [Related]  

  • 2. The insulin analog glargine during an unplanned pregnancy.
    Cechurová D; Lacigová S; Jankovec Z; Haladová I; Zourek M; Krcma M; Rusavý Z; Turek J
    Wien Klin Wochenschr; 2006 Oct; 118(19-20):619-20. PubMed ID: 17136338
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with the long-acting insulin analog degludec during pregnancy in women with type 1 diabetes: An observational study of 22 cases.
    Keller MF; Vestgaard M; Damm P; Mathiesen ER; Ringholm L
    Diabetes Res Clin Pract; 2019 Jun; 152():58-64. PubMed ID: 31102682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of insulin analogues in pregnancy.
    Lambert K; Holt RI
    Diabetes Obes Metab; 2013 Oct; 15(10):888-900. PubMed ID: 23489521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-acting insulins in the treatment of type 2 diabetes: a hard choice].
    Liebl A
    MMW Fortschr Med; 2015 Apr; 157(7):65-8. PubMed ID: 26012462
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic control by insulin detemir in basal-bolus therapy: treat-to-target study in children and adolescents with type 1 diabetes.
    Nimri R; Lebenthal Y; Shalitin S; Benzaquen H; Demol S; Phillip M
    Pediatr Diabetes; 2013 May; 14(3):196-202. PubMed ID: 23289822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A crossover comparison of glycemic variations in Japanese patients with type 1 diabetes receiving insulin glargine versus insulin detemir twice daily using continuous glucose monitoring (CGM): J COLLECTION (Jikei COmparison of Lantus and LEvemir with Cgm for Thinking Insulin OptimizatioN).
    Tsujino D; Nishimura R; Morimoto A; Tajima N; Utsunomiya K
    Diabetes Technol Ther; 2012 Jul; 14(7):596-601. PubMed ID: 22775404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of two insulin regimes in pregnancy complicated by diabetes mellitus.
    Nor Azlin MI; Nor NA; Sufian SS; Mustafa N; Jamil MA; Kamaruddin NA
    Acta Obstet Gynecol Scand; 2007; 86(4):407-8. PubMed ID: 17486460
    [No Abstract]   [Full Text] [Related]  

  • 10. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
    Hemmingsen B; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus.
    Cengiz E; Sherr JL; Erkin-Cakmak A; Weinzimer SA; Burke EN; Sikes KA; Urban AD; Tamborlane WV
    Endocr Pract; 2011; 17(6):862-6. PubMed ID: 21550949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
    Chico A; Saigi I; García-Patterson A; Santos MD; Adelantado JM; Ginovart G; de Leiva A; Corcoy R
    Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deleterious outcomes after abrupt transition from insulin glargine to insulin detemir in patients with type 1 diabetes mellitus.
    Kabadi UM
    Clin Drug Investig; 2008; 28(11):697-701. PubMed ID: 18840012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice- rather than once-daily basal insulin is associated with better glycaemic control in Type 1 diabetes mellitus 12 months after skills-based structured education in insulin self-management.
    Hopkinson HE; Jacques RM; Gardner KJ; Amiel SA; Mansell P
    Diabet Med; 2015 Aug; 32(8):1071-6. PubMed ID: 25982032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of insulin glargine and insulin detemir with NPH insulin in children and adolescents with type 1 diabetes mellitus receiving intensive insulin therapy.
    Dündar BN; Dündar N; Eren E
    J Clin Res Pediatr Endocrinol; 2009; 1(4):181-7. PubMed ID: 21274293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog.
    Raslova K
    Vasc Health Risk Manag; 2010 Jun; 6():399-410. PubMed ID: 20539842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.
    Johansen OE; Vanberg PJ; Kilhovd BK; Jørgensen AP
    Vasc Health Risk Manag; 2009; 5(1):121-8. PubMed ID: 19436668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-inferiority of insulin glargine versus insulin detemir on blood glucose variability in type 1 diabetes patients: a multicenter, randomized, crossover study.
    Renard E; Dubois-Laforgue D; Guerci B;
    Diabetes Technol Ther; 2011 Dec; 13(12):1213-8. PubMed ID: 21810024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial.
    Thalange N; Bereket A; Larsen J; Hiort LC; Peterkova V
    Diabet Med; 2013 Feb; 30(2):216-25. PubMed ID: 23094597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes.
    Mathiesen ER; Damm P; Jovanovic L; McCance DR; Thyregod C; Jensen AB; Hod M
    Diabetes Metab Res Rev; 2011 Sep; 27(6):543-51. PubMed ID: 21557440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.